Combo Product Firms Lose Patience As Regs, Guidance Are Delayed Again
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry firms especially eager to see proposed GMP and adverse event reporting rules.
You may also be interested in...
President Obama Freezes Pending Bush Regulations For Review
In one of his first acts after taking office, President Obama temporarily halted issuance of regulations from all federal departments and agencies until his own appointees have signed off on the rules
Imaging Industry Wants A Rewrite On FDA Contrast Indication Guidance
An FDA draft guideline outlining the regulatory pathway for imaging equipment makers seeking to add new contrast agent indication labeling needs an overhaul to include more explicit guidance for sponsors, manufacturers say
Industry Looks To FDA’s New Combo Products Chief For Answers
FDA's Office of Combination Products says it is getting back on track with new leadership in place after months of flux. Industry meanwhile is pushing the office to accelerate the release of rules and guidelines to help companies navigate the relatively new area of regulation